1,370
Participants
Start Date
May 31, 2014
Primary Completion Date
April 18, 2017
Study Completion Date
April 18, 2017
Tolvaptan (OPC-41061)
Tolvaptan tablets (15 or 30 mg) will be self-administered orally as split-dose regimens, once upon awakening and another approximately 8 to 9 hours later.
Placebo
Matching placebo tablets will be self-administered orally as split-dose regimens, once upon awakening and another approximately 8 to 9 hours later
Liège
Budapest
Brussels
Brussels
Camperdown
St Leonards
Concord
Westmead
New Lambton Heights
Antwerp
Leuven
Parkville
Reservoir
Richmond
Durban
Stavanger
Woolloongabba
Adelaide
Odense C
Bergen
Junín
Perth
Szeged
Launceston
Holstebro
Pécs
Cape Town
Aarhus C
Kortrijk
Viborg
Ghent
Aalborg
Aalst
New York
New York
New York
Rosedale
Mineola
Ciudad Real
Stockholm
Buffalo
Bethlehem
Doylestown
Philadelphia
Milan
Milan
Greenbelt
Rockville
Wheaton
Baltimore
Nahariya
Arlington
Charlottesville
Norfolk
Lecco
Montichiari
Morgantown
Pavia
Winston-Salem
Madrid
Madrid
Charlotte
Asheville
Orangeburg
Columbia
Charleston
Brest
Atlanta
Hanover
Augusta
Toulouse
Jacksonville
Bordeaux
Miami
Tampa
Port Charlotte
Tel Aviv
Montpellier
Ocala
Hudson
Birmingham
Huntsville
Mobile
Nashville
Nashville
Grenoble
Knoxville
Bologna
Düsseldorf
Seville
Seville
Modena
Gothenburg
Saint-Priest-En-Jarez
Columbus
Cleveland
Cleveland
Akron
Essen
Cincinnati
Valencia
Roseville
Detroit
Pontiac
Kalamazoo
Reims
Jilemnice
Ramat Gan
Vandœuvre-lès-Nancy
La Crosse
Minneapolis
Rochester
Fargo
Linköping
Grand Forks
Torrette Di Ancona
Chicago
St Louis
Wiesbaden
Kansas City
Wichita
Heidelberg
Lyon
Pierre-Bénite
Bari
Örebro
Lafayette
Baton Rouge
Uppsala
Arlington
Houston
McAllen
Aurora
Napoli
Denver
Munich
Meridian
Tempe
Phoenix
Tucson
Las Vegas
Reno
Los Angeles
Los Angeles
Nuremberg
La Jolla
San Francisco
Portland
Wenatchee
Yaroslavl
Saint Petersburg
Saint Petersburg
Oradea
Krasnoyarsk
Petah Tikva
Ashkelon
Jerusalem
New Haven
Boston
Springfield
Eatontown
Voorhees Township
Chapel Hill
Houston
Burlington
Bahía Blanca
Ciudad Autonoma
Ciudad Autonoma
Ciudad Autonoma
Ciudad Autonoma
Ciudad Autonoma
Pergamino
Pilar
Sarandí
Córdoba
Córdoba
Córdoba
Edmonton
St. John's
Scarborough Village
Toronto
Toronto
Toronto
Greenfield Park
Montreal
Montreal
Brno
České Budějovice
Hradec Králové
Jihlava
Liberec
Ostrava
Prague
Prague
Tábor
Dresden
Groningen
Nijmegen
Oslo
Ciechanów
Golub-Dobrzyń
Krakow
Lodz
Lodz
Lublin
Warsaw
Wroclaw
San Juan
Bucharest
Bucharest
Pretoria
L'Hospitalet de Llobregat
Stockholm
Exeter
Hull
Brighton
London
Manchester
Salford
Stevenage
Inverness
Leicester
Edinburgh
Liverpool
Middlesbrough
Sheffield
Stoke-on-Trent
Newcastle upon Tyne
Coventry
Swansea
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY